United States: Petitioner's Analogous Art Argument Was Not So Obvious When Reversing The PTAB - Marshall, Gerstein & Borun LLP
Wednesday, 5 July 2023
In Sanofi-Aventis Deutschland GMBH v. Mylan Pharms, Inc., No. 21-1981 (Fed. Cir. May 9, 2023), the Federal Circuit reversed the PTAB's finding that Sanofi's patent claims were obvious...
|
||||
You Might Like |
||||
